3rd Quarter - Report

PRIME POLICY GROUP for GLAXOSMITHKLINE

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Vaccines Drug Pricing

LobbyistCovered position, as disclosed
MITCHELL VAKERICS —
VICKIE WALLING —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Copyright/Patent/Trademark CPT

HR 9 patent legislation

LobbyistCovered position, as disclosed
MITCHELL VAKERICS —
VICKIE WALLING —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 9 (114th)

Homeland Security HOM

21st Century Cures Act

LobbyistCovered position, as disclosed
VICKIE WALLING —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

340 B Drug Program

LobbyistCovered position, as disclosed
MITCHELL VAKERICS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.